TwinBeech Capital’s 89bio ETNB Stock Holding History

TwinBeech Capital’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-86,689	Closed	-$968K	–	641
2023 Q4	$968K	Sell	86,689 -49,427	-36%	-$454K	0.02%	491
2023 Q3	$2.1M	Buy	+136,116	New	+$2.28M	0.04%	405

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

TwinBeech Capital's ETNB Position: Q1 2024 in Review

TwinBeech Capital sold out of 89bio (ETNB) in Q1 2024, closing a stake of 86,689 shares — an estimated $968K sold.

TwinBeech Capital first reported a position in ETNB in Q3 2023 and held it in 2 quarters. The position peaked at $2.1M in Q3 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

TwinBeech Capital reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
TwinBeech Capital sold 86,689 89bio shares in Q1 2024, an estimated $968K.
TwinBeech Capital first reported a position in 89bio in Q3 2023 and held it in 2 quarters.
TwinBeech Capital's 89bio position peaked at $2.1M in Q3 2023.
150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on TwinBeech Capital's 13F filing for Q1 2024, filed 15 May 2024.